期刊文献+

加味胸痹汤对冠心病心绞痛患者TNF-α、VEGF水平的影响 被引量:6

Influence of Xiongbitong Decoction on TNF-α and VEGF Levels of Coronary Heart Angina Patients
下载PDF
导出
摘要 目的:观察加味胸痹汤对冠心病心绞痛患者TNF-α、VEGF水平的影响,探讨在冠心病发病中的部分可能机制。方法:将60例冠心病稳定型心绞痛患者随机分成治疗组和对照组,每组各30例,两组均根据病人病情选用ACE抑制剂、β受体阻滞剂、抗血小板聚集等最优化的西药治疗;治疗组在以上治疗的基础上加用中药加味胸痹汤口服,疗程结束后观察疗效与结果。结果:两组治疗后中医证候疗效改善情况比较有统计学差异,P<0.05,但心电图的改善情况无统计学意义。治疗组治疗后的TNF-α含量明显低于西药对照组治疗后,(P<0.05),中药治疗组血清VEGF的含量较治疗前明显升高(P<0.05),而西药对照组血清VEGF的含量较治疗前升高不明显(P>0.05)。结论:中药加味胸痹汤可以提高中医证候疗效,本方有抑制血管内皮炎性细胞分泌TNF-α,保护血管内皮功能的作用。对促进血管内皮细胞分泌VEGF具有明显的作用,从患者症状明显改善甚至消失,推测该药可能有促进缺血心肌血管新生的作用,这可能是该药对于缺血心肌保护作用机制之一。 Objective : To observe the effect of Xiongbi Decoction on TNF - a and VEGF levels of coronary heart disease patients with angina pectoris, and to explore the possible mechanisms in the pathogenesis of coronary heart disease. Methods : 60 cases of coronary heart disease in patients with stable angina were randomly divided into treatment group and control group, 30 in each group, based on the patients'conditions, ACE inhibitors, β -blockers, anti- platelet aggregation optimization were selected. Treatment group on the basis of the above treatment added with the Xiongbitong Decoction. The effects were observed after treatment. Results: After treatment, TCM syndrome was improved with statistical difference ( P 〈 0.05 ), but there was no statistically significant ECG improvement. After treatment, TNF - a level was significantly lower than that of the comparison group ( P 〈 0.05 ), treatment group serum levels of VEGF were significantly increased ( P 〈 0.05 ), while the serum VEGF content in control group was not obviously increased ( P 〉 0.05 ). Conclusion : Xiongbitong Decoction can improve the TCM syndromes, the party inflammatory ceils to inhibit vascular endothelial secretion of TNF -a, and protect the role of vascular endothelial function. The promotion of vascular endothelial cells to secrete VEGF has a distinct role, speculating that the drug may have a role to promote myocardial angiogenesis, which may be one of the mechanisms of the protective effect of the drug for ischemic myocardium.
作者 王文林
机构地区 义乌市中心医院
出处 《中华中医药学刊》 CAS 2013年第6期1446-1449,共4页 Chinese Archives of Traditional Chinese Medicine
关键词 冠心病心绞痛 加味胸痹汤 细胞因子 TNF-Α VEGF angina pectoris Xiongbitong Decoction cytokine TNF - a VEGF
  • 相关文献

参考文献11

  • 1Elaine P, Moniek PM. C-reactive protein in atherosclero8is: A causal factor [ J ]. cardiov, cular Research,2006,71 ( 1 ) : 30. 被引量:1
  • 2张嘉莹,朱中玉,李牧蔚,陈岩,王现青.青年急性心肌梗死患者脂蛋白(a)水平的变化及其意义[J].临床心血管病杂志,2002,18(10):500-502. 被引量:248
  • 3郑筱萸主编..中药新药临床研究指导原则 试行[M].北京:中国医药科技出版社,2002:392.
  • 4国家中医药管理局编..中医病证诊断疗效标准[M].南京:南京大学出版社,1994:218.
  • 5中西医结合治疗冠心病心绞痛及心律失常座谈会.冠心病心绞痛及心电图疗效评定标准[S].1979. 被引量:2
  • 6中华人民共和国卫生部医政司编..中国常见心肺血管疾病诊治指南[M].北京:科学出版社,2000:667.
  • 7江一青,刘朝中,朱国英,等.现代冠心病学[M].北京:人民军医出版社,2001:609. 被引量:21
  • 8Rangogiannis N G,Smith CW, Entman ML. The inflammatory re- sponse in myocardial infarction [ J ]. Cardiov c Res,2002 ,53 :31. 被引量:1
  • 9Xu X H, Chen J G, Zhu J Z. Primary study of vcular endothelial growth factor immunohistochemical staining in the diagnosis of early acute myocardial ischemia[J]. Forensic Sci Int, 2001, 118 (1): 11. 被引量:1
  • 10陈长勋..中药药理学[M],2006.

二级参考文献7

  • 1Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384. 被引量:1
  • 2Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046. 被引量:1
  • 3Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118. 被引量:1
  • 4Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111. 被引量:1
  • 5Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280. 被引量:1
  • 6Maeda S, Abe A, Seishima M, et al. Transient change of serum lipoprotein (a) as an acute phase protein. Atherosclerosis, 1989,78(1):145-150. 被引量:1
  • 7Greory Y H, Gordon D L. Fibrin D-dimer: A useful marker of thrombogenesis? Clini Sci,1995(89):205-214. 被引量:1

共引文献360

同被引文献60

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部